D-Wave Quantum: Two Cut Targets, a Contested Lawsuit Window and a 15-Second Solver All Converge on November 10
Published on 11/08/2026 at 11:31 | Editorial boerse-global.de
D-Wave Quantum shares jumped 19% on Friday, catching the updraft from an industry-wide rally set off by rival IonQ. According to media reports, better-than-expected quarterly figures and a raised revenue outlook from the competitor gave the quantum computing sector a tailwind. D-Wave itself released no quarterly numbers that day — traders, media reports suggest, were already positioning themselves ahead of the company's own report.
That report now has a date. D-Wave has scheduled third-quarter 2026 results for November 10, before the market opens, covering the quarter ended September 30. A webcast is set to follow at 8:00 a.m. Eastern Time.
Two houses trim targets, keep their buy calls
The week's analyst actions show how cautiously even fundamentally optimistic observers are modelling the stock. On Tuesday, B. Riley Securities analyst Craig Ellis cut his price target to $27 from $40, according to media reports, while keeping his buy rating. Wedbush followed on Thursday: analyst Matt Bryson lowered his target to $30 from $37 and reaffirmed his buy recommendation. Bryson pointed to lower growth assumptions for the next two years as well as developments including IonQ's capital raise.
The takeaway for investors is a tension worth watching: a positive rating can travel alongside meaningfully reduced expectations. The reasoning and revised assumptions behind each call arguably matter more than the label attached to it. Both houses trimmed their marks without abandoning their constructive stance — support that holds only if D-Wave can deliver operationally against the lowered bar.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
A lawsuit window, with claims still unproven
Weighing on the story is litigation covering investors who bought shares between February 26 and August 25, 2026. The allegations are claims, not established facts — a distinction that belongs squarely in any assessment of the matter. The legal risk warrants attention for as long as the asserted claims remain unresolved.
That makes it important to separate sector-wide confidence from company-specific proof. Friendlier sentiment toward quantum computing can lift the stock; a durable economic re-rating, however, requires technical improvements to show up in the business itself. The next set of company figures is where investors must test that link.
Clinical promise, provisional by design
Company news has also come on the research front. On Monday, D-Wave highlighted the use of its hardware for lung-cancer prognosis on a limited data set. Researchers at Florida Atlantic University examined a quantum-assisted method using support vector machines, and according to D-Wave the approach reached 91.90% accuracy on the hardware.
The researchers themselves described the results as preliminary and called for validation against independent clinical data sets. The reported accuracy rate therefore carries an explicit validation caveat; no confirmed clinical application was announced.
D-Wave Quantum at a turning point? This analysis reveals what investors need to know now.
A solver that works faster, if customers cash in
On the product side, D-Wave reported progress on Wednesday with its hybrid Stride solver. According to the company, the improved version found better solutions within 15 seconds in benchmark tests than its predecessor did in 120 seconds.
Such gains lend substance to the technological case — provided customers can extract economic value from them. Better software, a viable business trajectory and careful handling of the legal risks are the three strands that need to come together, and the November 10 report is the concrete occasion to check how much company-specific conviction actually sits behind the sector's tailwind.
Ad
D-Wave Quantum Stock: New Analysis - 8 November
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
